We are live on ! Find out more
CELUW icon

Celularity Inc
CELUW

21 hedge funds and large institutions have $9.84M invested in Celularity Inc in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more capital invested

Capital invested by funds: $6.6M → $9.84M (+$3.24M)

0% more funds holding

Funds holding: 21 → 21 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

Holders
21
Holders Change
–
Holders Change %
0%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
5
Closed
2
Calls
$2.09M
Puts
–
Net Calls
+$2.09M
Net Calls Change
+$1.44M

Top Buyers

Rank Fund Capital Flow
1
PFM
Privium Fund Management
Netherlands
+$813K
2
ICM
Ionic Capital Management
New York
+$216K
3
Walleye Capital
Walleye Capital
New York
+$212K
4
CCM
Context Capital Management
California
+$40.7K
5
WAM
Wolverine Asset Management
Illinois
+$26.6K

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$1.26M
2
ICMH
Integrity Capital Management (HK)
Hong Kong
-$43K
3
EPM
Equitec Proprietary Markets
Illinois
-$42.6K
4
WAM
Warberg Asset Management
Illinois
-$37K
5
AA
AQR Arbitrage
Connecticut
-$36K
Name Holding Trade Value Shares
Change 		Change in
Stake
ICM
1
Ionic Capital Management
New York
$2.84M +$216K +265,106 +15%
PFM
2
Privium Fund Management
Netherlands
$2.29M +$813K +998,516 +148%
Walleye Capital
3
Walleye Capital
New York
$1.31M +$212K +260,763 +37%
LA
4
Linden Advisors
New York
$1.09M -$1.26M -1,547,264 -66%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
5
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$480K – – –
CL
6
CSS LLC
Illinois
$359K -$2.12K -2,600 -1%
DKCM
7
Davidson Kempner Capital Management
New York
$312K – – –
PI
8
PEAK6 Investments
Illinois
$235K – – –
CCM
9
Context Capital Management
California
$206K +$40.7K +50,000 +50%
EPM
10
Equitec Proprietary Markets
Illinois
$202K -$42.6K -52,314 -26%
SC
11
Shay Capital
New York
$122K – – –
AA
12
AQR Arbitrage
Connecticut
$98K -$36K -44,194 -38%
EL
13
EMFO LLC
Florida
$96K – – –
YCM
14
Yakira Capital Management
Connecticut
$45K -$31.4K -38,556 -54%
WAM
15
Wolverine Asset Management
Illinois
$44K +$26.6K +32,678 New
HF
16
HRT Financial
New York
$24K – – –
OMC
17
Old Mission Capital
Illinois
$22K +$12.9K +15,776 New
BPGAM
18
BTG Pactual Global Asset Management
Bermuda
$21K – – –
Verition Fund Management
19
Verition Fund Management
Connecticut
$21K – – –
BRWM
20
B. Riley Wealth Management
Tennessee
$14K – – –
UBS Group
21
UBS Group
Switzerland
$5K +$2.9K +3,566 +44,575%
ICMH
22
Integrity Capital Management (HK)
Hong Kong
– -$43K -50,023 Closed
WAM
23
Warberg Asset Management
Illinois
– -$37K -43,603 Closed

CELUW Hedge Fund Activity: Q1 2022 in Review

21 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Celularity Inc (CELUW) for Q1 2022, worth a combined $9.84M — up 49% from $6.6M a quarter earlier.

Fund positioning in CELUW was balanced in Q1 2022: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 5 trimmed.

The largest buyer was Privium Fund Management, adding an estimated $813K. The largest seller was Linden Advisors, cutting an estimated $1.26M.

  • 21 institutional investors held Celularity Inc (CELUW) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $9.84M of Celularity Inc stock for Q1 2022, up 49% quarter-over-quarter.
  • 2 funds opened new Celularity Inc positions in Q1 2022 and 2 closed out, a net change of 0 holders.
  • The largest Celularity Inc buyer in Q1 2022 was Privium Fund Management, an estimated $813K added.
  • The largest Celularity Inc seller in Q1 2022 was Linden Advisors, an estimated $1.26M sold.

Based on aggregated 13F filings for Q1 2022.